Mucormycosis and Aspergillosis have been Linked to Covid-19-Related Fungal Infections in India

  title={Mucormycosis and Aspergillosis have been Linked to Covid-19-Related Fungal Infections in India},
  author={Chittaranjan Baruah},
  journal={Advancements in Case Studies},
  • C. Baruah
  • Published 4 June 2021
  • Medicine, Biology
  • Advancements in Case Studies
Mucormycosis and aspergillosis have been recorded in alarmingly high numbers in India in recent decades. Even though fungal infections contribute significantly to human morbidity and mortality, the effect of these diseases on COVID-19 patients is unknown. Mucormycosis and aspergillosis were identified as two post-acute symptoms in COVID-19 patients in this study. Coronavirus 2 of the severe acute respiratory syndrome causes direct damage to the airway epithelium, allowing Mucormycosis and… 
2 Citations
Endoscopic Injection Treatment of Vesicoureteral Reflux in Children: Meeting with the Factors Involved in the Success Rate
Goeckerman regimen is a very effective, safe and low-cost therapy that modulates the immune system reactivity, ameliorates the severity of the disease and reduces the levels of alarmins reflecting the presence and intensity of inflammation.


Epidemiology of Mucormycosis in India
The spectrum of etiological agents causing mucormycosis is unique as Apophysomyces elegans is the second most common pathogen after Rhizopus oryzae and many new agents are identified causing the disease.
Epidemiology and outcome of zygomycosis: a review of 929 reported cases.
  • M. Roden, T. Zaoutis, T. Walsh
  • Medicine
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2005
Outcome from zygomycosis varies as a function of the underlying condition, site of infection, and use of antifungal therapy; however, infection due to Cunninghamella species and dissemination were independently associated with increased rates of death.
When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis
Treating physicians should have a high suspicion for CAMCR in patients with uncontrolled diabetes mellitus and severe COVID-19 presenting withrhino-orbital or rhino-cerebral syndromes, and nearly all CAMCR infections were proven.
Aspergillus fumigatus and Aspergillosis in 2019
The emergence of new concepts, such as nutritional immunity and the integration and rewiring of multiple fungal metabolic activities occurring during lung invasion, has helped to redefine the opportunistic pathogenesis of A. fumigatus.
An Overview of Reptile Fungal Pathogens in the Genera Nannizziopsis, Paranannizziopsis, and Ophidiomyces
Information gathered from PCR assays and molecular speciation will help in outlining pathogenic potential and contagion risks associated with each of these newly recognized fungal species and allow for a more comprehensive understanding of the ecology, distribution, and host range of these pathogens.
Global Epidemiology of Mucormycosis
With the change in epidemiology of mucormycosis country-wise studies are warranted to estimate disease burden in different risk groups, analyse the clinical disease pattern and identify the new etiological agents.
The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports.
  • W. Jeong, C. Keighley, S. Chen
  • Medicine
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
  • 2019
Clinical significance of hyperattenuating mucoid impaction in allergic bronchopulmonary aspergillosis: an analysis of 155 patients.
HAM impaction in ABPA is associated with initial serologic severity and frequent relapses but does not seem to influence complete remission.
Prevalence of Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma at a tertiary care center in North India
A high prevalence rate of ABPA was observed at the chest clinic in Uttar Pradesh, although comparable with published data from other tertiary centers, it does not represent the true prevalence rates in asthmatics because of high chances of referral bias.